Beneficial therapeutic effects of solubilized amphotericin B after oral administration in experimental coccidioidomycosis, histoplasmosis, and cryptococcosis in mice.
D000284:Administration, Oral; D000666:Amphotericin B; D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology*; D003047:Coccidioidomycosis; D003453:Cryptococcosis; D005659:Fungicides, Industrial; D006660:Histoplasmosis; D051379:Mice
D000935:Antifungal Agents; D005659:Fungicides, Industrial; D000666:Amphotericin B
COCCIDIOIDOMYCOSIS/experimental; CRYPTOCOCCOSIS/experimental; FUNGICIDES/pharmacology; HISTOPLASMOSIS/experimental